If you are a vaccine company executive, it’s time to slam the brakes

If you are a vaccine company executive, it’s time to slam the brakes. By Alex Berenson.

Here’s what Albert Bourla, Pfizer’s chief executive officer, said on Monday in an interview on CNBC:

The hope is that we will achieve something that will have way, way better protection, particularly against infections because the protection against the hospitalizations and the severe disease, it is, it is reasonable right now, with the current vaccines as long as you are having let’s say the third dose. …

What this means:

Protection against “severe disease” is “reasonable right now” for people who have taken a “third dose” of Pfizer’s vaccine.

Put aside the fact that even those words are at best an optimistic interpretation of current data.

Put aside the fact that Pfizer has NEVER compared a three-dose vaccine regimen to a placebo in a clinical trial.

Put aside the fact that “reasonable right now” suggests that any effect of a third dose will not last.

What the chief executive of Pfizer is telling you is that if you received two doses of his company’s vaccine last year, your protection is gone. Even against “the hospitalizations and the severe disease.”

Most people will figure out soon that the vaccines are temporary and ineffective:

Most people don’t understand yet how badly they were conned.

But they will. …

The data out of Europe are similar. The only reason the American data look different is that we don’t get to see the raw numbers. Instead, health authorities provide meaningless adjusted rate ratios (adjusted for age of vaccinated people, but NOT for healthy vaccine user bias – the fact that frailest elderly people are often not vaccinated because they cannot be.) Further, American hospitals report people as unvaccinated when their vaccine status is “unknown,” further skewing the ratios.

Vaccine harm — strong signs that some of it is cumulative:

The flip side is adverse events. We don’t know how bad those are after a third dose, much less a fourth or fifth or more. (How can we? Remember, the companies didn’t test three doses against placebo.)

But the third-shot myocarditis data looks bad. It suggests a dose-dependent response. And the rise in all-cause deaths across Europe in the last few months cannot be ignored, even if the health authorities are ignoring it.

Pfizer is now backpedaling away from vaccines, to their even more expensive product:

I suspect the smartest people at the companies are increasingly aware of the potential crisis of repeated dosing. Which may be why Bourla also said in the CNBC interview, “I don’t know if there is a need for a fourth booster.”

What? In the same interview where Pfizer’s CEO warned people not to expect long-lasting protection from a third shot — “reasonable right now” — he also pivoted away from more boosters?

Instead Bourla talked up Paxlovid, his company’s new $530 per treatment antiviral. “This is where most of the effort of most of the governments is moving.” …

Will Pfizer soon be the most despised company in history?

More important for Bourla, the real risk to Pfizer — and to him — comes from side effects. People will be angry when they figure out that they’ve been conned into taking vaccines that didn’t work. But most of them won’t be furious, especially since Omicron appears much milder than earlier variants. Zero efficacy probably won’t destroy Pfizer or get anyone indicted.

But side effects might. People will be FURIOUS if they think they been conned into taking vaccines that didn’t work and potentially hurt them, or their parents, or their kids.

Right now the rate of reported serious vaccine injury is just low enough that the companies and vaccine fanatics can argue it’s not real, it’s a statistical artifact, the VAERS reports are fake (they’re not), etc. The third dose appears to be changing that equation somewhat.

Who knows what future doses will bring? Nobody, including Albert Bourla, though his scientists may have shot up enough mice and monkeys to give him a better idea than the rest of us. …

The prudent move for Albert Bourla, Doctor of Veterinary Medicine, PhD., is to begin to tamp expectations for vaccines, slow-walk more boosters, and hope that Omicron does his job for him. His biggest problem is probably that the public health authorities are a lot stupider than he is and continue to push boosters.

This strongly suggests that the vaccine drive is driven by commercial greed and bureaucratic corruption and stupidity, rather than any conspiracy to cull or maim the population via vaccines.